The decision by President Donald Trump to temporarily exempt medical sterilization facilities that use the colorless gas ethylene oxide from tighter emissions standards has sparked controversy and concern among residents living near these plants in Georgia. Last year, the Biden administration finalized new emissions limits for facilities using ethylene oxide, also known as EtO, with the aim of reducing emissions by 90% and protecting nearby residents.
However, Trump’s recent proclamation extends the deadline for these facilities to meet the new requirements, citing concerns about the commercial viability of the technology needed to comply with the regulations. The extension will give sterilization plants two more years to make necessary upgrades, with the argument that the current rules could lead to the closure of existing facilities and disrupt the supply of medical equipment, posing a threat to national security.
Some of the affected facilities in Georgia include Becton Dickinson (BD) plants in Covington and Madison, the Sterigenics plant in Cobb County, Kendall Patient Recovery (KPR) near Augusta, and Sterilization Services of Georgia’s facility near Atlanta. Ethylene oxide is a critical component in medical and dental settings for sterilizing equipment and devices that cannot be effectively sterilized by other methods. Approximately 20 billion medical devices are sterilized with EtO each year in the US.
Despite its essential role in sterilization, ethylene oxide has been classified as a human carcinogen by the EPA since 2016 and has been linked to various types of cancers. Concerns about health risks from exposure to ethylene oxide led to lawsuits against facilities in Georgia, with Sterigenics settling claims for $35 million in 2023. Hundreds of lawsuits are still pending against BD, Sterigenics, and KPR, with a $20 million verdict awarded to a retired truck driver in a landmark trial in May.
The debate over the use of ethylene oxide in sterilization facilities continues to raise questions about the balance between public health and national security concerns. The temporary exemption granted by President Trump has reignited discussions about the safety of these facilities and the need for stricter regulations to protect both workers and nearby residents from the harmful effects of ethylene oxide exposure. Bard, a medical device company, has recently come under scrutiny for its role in causing non-Hodgkin lymphoma in patients. The company has been accused of using ethylene oxide (EtO) in its sterilization processes, a known carcinogen that has been linked to various health risks, including cancer.
Many lawsuits have been filed against Bard, with plaintiffs claiming that exposure to EtO during medical procedures involving Bard’s products led to their development of non-Hodgkin lymphoma. Michael Geoffroy, an attorney involved in these cases, has criticized the Trump administration for loosening regulations on EtO emissions, stating that it will only worsen the situation and put communities at risk.
In response to the allegations, BD, Bard’s parent company, has stated that they are committed to safe operations and compliance with regulations. They have already implemented new emissions controls at some facilities and are working towards meeting the new standards. However, they claim that acquiring the necessary equipment to comply with the regulations may be challenging within the given timeframe.
The Trump administration has granted exemptions to certain facilities, including those using EtO for sterilization, citing a lack of available technology and national security interests. Mindy Goldstein, an environmental law expert, has raised concerns about the lack of evidence supporting these claims and the potential for legal challenges.
While the Trump administration is reevaluating the EtO regulations put in place by the Biden administration, it remains unclear if they will seek to change the standards. This move is part of a broader effort to roll back environmental regulations implemented by previous administrations, raising concerns about the impact on public health and the environment.
